To provide a novel photoelectric conversion device that is highly convenient, useful, or reliable. The photoelectric conversion device includes a first electrode, a second electrode, and a first unit. The first unit is located between the first electrode and the second electrode. The first unit contains a first electron-donating material and a first electron-accepting material. The first electron-donating material is a condensed aromatic compound, and the first electron-accepting material has a perylene skeleton and two or more alkyl groups. The alkyl groups each independently have 1 to 13 carbon atoms.

To provide a novel photoelectric conversion device that is highly convenient, useful, or reliable. The photoelectric conversion device includes a first electrode, a second electrode, and a first unit. The first unit is located between the first electrode and the second electrode. The first unit contains a first electron-donating material and a first electron-accepting material. The first electron-donating material is a condensed aromatic compound, and the first electron-accepting material has a perylene skeleton and two or more alkyl groups. The alkyl groups each independently have 1 to 13 carbon atoms.

A condensed cyclic compound represented by Formula 1: ##STR00001## wherein in Formula 1, Ar.sub.1 and R.sub.1 to R.sub.8 are the same as described in the specification.

A condensed cyclic compound represented by Formula 1: ##STR00001## wherein in Formula 1, Ar.sub.1 and R.sub.1 to R.sub.8 are the same as described in the specification.

The present invention relates to an organic light emitting device comprising a light emitting layer and an electron transport layer which satisfy the following mathematical expressions, E.sub.HOMO-ET>E.sub.HOMO-BH and E.sub.LUMO-ET>E.sub.LUMO-GH, and having improved driving voltage, efficiency, and lifetime.

The present invention relates to an organic light emitting device comprising a light emitting layer and an electron transport layer which satisfy the following mathematical expressions, E.sub.HOMO-ET>E.sub.HOMO-BH and E.sub.LUMO-ET>E.sub.LUMO-GH, and having improved driving voltage, efficiency, and lifetime.

The invention relates to compounds and methods of using said compounds, as well as pharmaceutical compositions containing such compounds, for treating diseases and conditions mediated by TEAD, such as cancer.

The invention relates to compounds and methods of using said compounds, as well as pharmaceutical compositions containing such compounds, for treating diseases and conditions mediated by TEAD, such as cancer.

Mutations in oncogenes and tumor suppressors contribute to the development and progression of cancer. The present disclosure describes compounds and methods that restore DNA binding affinity of p53 mutants. The compounds of the present disclosure can bind to mutant p53 and restore the ability of the p53 mutant to bind DNA and activate downstream effectors involved in tumor suppression. The disclosed compounds can be used to reduce the progression of cancers that contain a p53 mutation.

A novel organic compound is provided. An organic compound represented by General Formula (G1) below is provided. Note that in General Formula (G1), one of A and B represents a group represented by General Formula (g1) below, and the other of A and B, R1 to R8, and R11 to R14 each independently represent any one of hydrogen, an alkyl group having 1 to 6 carbon atoms, a cyclic hydrocarbon group having 3 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a cyano group, a halogen, a haloalkyl group having 1 to 6 carbon atoms, and a substituted or unsubstituted aromatic hydrocarbon group having 6 to 60 carbon atoms. R9 and R10 each independently represent any one of hydrogen, an alkyl group having 1 to 6 carbon atoms, a cyclic hydrocarbon group having 3 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a cyano group, a halogen, a haloalkyl group having 1 to 6 carbon atoms, and a substituted or unsubstituted phenyl group. Ar represents a substituted or unsubstituted aryl group having 6 to 13 carbon atoms.

##STR00001##